• Sep 15, 2026

  $27.85-3.33%

  Hims & Hers Health faced additional securities class action announcements tied to the earlier FTC lawsuit, with law firms publicizing investor deadlines and litigation opportunities [1][2][3]. The stock fell 3.33% even as the broad market, tracked by the S&P 500 ETF, slipped only 0.46%, meaning the decline was not shared by the broader market [4].

  • 1Pr Newswire
  • 2Pr Newswire
  • 3Pr Newswire
  • 4Broad market

• Sep 14, 2026

  $28.81+4.73%

  Hims & Hers Health shares rose 4.73% on a day when the broad market, tracked by the S&P 500 ETF, fell 0.45%, so the move was not shared by the broader market [1].

  • 1Broad market

• Sep 11, 2026

  $27.51+0.26%

• Sep 10, 2026

  $27.44-1.65%

  PR Newswire reported that Hims & Hers Health faced a securities class action after an FTC lawsuit was revealed, and the report said that disclosure drove the stock sharply lower [1].

  • 1Pr Newswire

• Sep 9, 2026

  $27.90-0.96%

• Sep 8, 2026

  $28.17+1.66%

• Sep 4, 2026

  $27.71-0.40%

Closing prices for HIMS. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.